How to Pay for Million-Dollar Drugs

A.M. Edition for September 5th: Insurers are scrambling to blunt the expense of new drugs that can carry prices of more than $2 million per treatment, offering new setups aimed at making the cost of gene therapies more manageable for employers. The Wall Street Journal's Anna Mathews has more.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Om Podcasten

What's News brings you the headlines and business news that move markets and the world—twice every weekday. In about 15 minutes, get caught up on the best Wall Street Journal scoops and exclusives, with insight and analysis from the award-winning reporters that broke the stories. Hosted by Annmarie Fertoli and Luke Vargas.